Clinical Trial Update: Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of Sovateltide in neonates with Hypoxic-Ischemic Encephalopathy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy
• Neonatal Asphyxia
• Neonatal Encephalopathy

Drugs mentioned

• Sovateltide (sovateltide)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia | Phase 2 | Status: RECRUITING